Literature DB >> 23276799

PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.

Pradeep S Tanwar1, Tomoko Kaneko-Tarui, Ho-Joon Lee, Lihua Zhang, Jose M Teixeira.   

Abstract

Epithelial ovarian cancer is a heterogeneous disease that is subdivided into five major histotypes but the mechanisms driving their differentiation are not clear. Mutations in adenomatous polyposis coli (APC) and β-catenin are commonly observed in the human ovarian endometrioid adenocarcinoma (OEA) patients. However, the mechanisms subsequent to APC deletion in ovarian tumorigenesis have not been well characterized. We have conditionally deleted APC in the murine ovarian surface epithelium (OSE) and showed that its loss leads to development of epithelial inclusion cysts. High-grade OEAs with tightly packed villoglandular histology were observed in older APC-deleted mice. Phosphatase and tensin homolog (PTEN) expression was elevated in the early lesions but lost after progression to the more advanced tumors. Knockdown of APC or expression of a gain-of-function β-catenin similarly induced human OSE cells to develop tumors with endometrioid histology in xenografts. Expression of HOXA10 was induced in both the advanced APC-deleted murine tumors and in the tumor xenografts of human OSE cells with knocked-down APC. These results show that reduced APC activity is sufficient to induce formation of epithelial inclusion cysts and support OEA development and suggest that induced HOXA10 expression and loss of PTEN are key mechanisms driving endometrioid histotype differentiation and progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276799      PMCID: PMC3616672          DOI: 10.1093/carcin/bgs405

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  56 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Authors:  Daniela M Dinulescu; Tan A Ince; Bradley J Quade; Sarah A Shafer; Denise Crowley; Tyler Jacks
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

3.  Causes of death in familial adenomatous polyposis.

Authors:  T S Galle; K Juel; S Bülow
Journal:  Scand J Gastroenterol       Date:  1999-08       Impact factor: 2.423

4.  High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

Authors:  Michael H Roh; Yosuf Yassin; Alexander Miron; Karishma K Mehra; Mitra Mehrad; Nicolas M Monte; George L Mutter; Marisa R Nucci; Geng Ning; Frank D Mckeon; Michelle S Hirsch; Xian Wa; Christopher P Crum
Journal:  Mod Pathol       Date:  2010-06-18       Impact factor: 7.842

5.  HOXA10 expression in endometrial adenocarcinoma.

Authors:  Danielle B Lane; Thomas J Rutherford; Hugh S Taylor
Journal:  Tumour Biol       Date:  2004 Sep-Dec

6.  Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.

Authors:  Marie-Noëlle Laguë; Marilène Paquet; Heng-Yu Fan; M Johanna Kaartinen; Simon Chu; Soazik P Jamin; Richard R Behringer; Peter J Fuller; Andrew Mitchell; Monique Doré; Louis M Huneault; Joanne S Richards; Derek Boerboom
Journal:  Carcinogenesis       Date:  2008-08-06       Impact factor: 4.944

Review 7.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.

Authors:  Koji Aoki; Makoto M Taketo
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

8.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

9.  Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.

Authors:  Pradeep S Tanwar; LiHua Zhang; Tomoko Kaneko-Tarui; Michael D Curley; Makoto M Taketo; Poonam Rani; Drucilla J Roberts; Jose M Teixeira
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

10.  Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.

Authors:  Shun Liang; Nuo Yang; Yue Pan; Shan Deng; Xiaojuan Lin; Xiaojun Yang; Dionyssios Katsaros; Katherine F Roby; Thomas C Hamilton; Denise C Connolly; George Coukos; Lin Zhang
Journal:  PLoS One       Date:  2009-01-27       Impact factor: 3.240

View more
  12 in total

1.  HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.

Authors:  Qingyu Yang; Qi Zhang; Xuewu Zhang; Lei You; Wenbiao Wang; Weiyong Liu; Yang Han; Chunqiang Ma; Wei Xu; Junbo Chen; Hua Yang; Pin Wan; Yao Zhou; Yingle Liu; Kailang Wu; Ziwen Yang; Jianguo Wu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

2.  Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.

Authors:  Bingbing Yan; Fuqiang Yin; Q I Wang; Wei Zhang; L I Li
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

3.  LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.

Authors:  Juelan Wang; Wenqian Xu; Yangke He; Qi Xia; Siwei Liu
Journal:  Inflamm Res       Date:  2018-10-11       Impact factor: 4.575

4.  Integrated Bioinformatic Analysis of the Correlation of HOXA10 Expression with Survival and Immune Cell Infiltration in Lower Grade Glioma.

Authors:  Ting Wang; Mingqian Liu; Ming Jia
Journal:  Biochem Genet       Date:  2022-07-14       Impact factor: 2.220

5.  HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells.

Authors:  Xian-Ping Cui; Cheng-Kun Qin; Zhen-Hai Zhang; Zhong-Xue Su; Xin Liu; Shi-Kang Wang; Xing-Song Tian
Journal:  Dig Dis Sci       Date:  2014-01-25       Impact factor: 3.199

6.  The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.

Authors:  Mamadou Keita; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

7.  miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.

Authors:  Lili Jiang; Chanjuan Wang; Fangyong Lei; Longjuan Zhang; Xin Zhang; Aibin Liu; Geyan Wu; Jinrong Zhu; Libing Song
Journal:  Oncotarget       Date:  2015-04-10

Review 8.  ARID1A gene mutation in ovarian and endometrial cancers (Review).

Authors:  Takashi Takeda; Kouji Banno; Ryuichiro Okawa; Megumi Yanokura; Moito Iijima; Haruko Irie-Kunitomi; Kanako Nakamura; Miho Iida; Masataka Adachi; Kiyoko Umene; Yuya Nogami; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Oncol Rep       Date:  2015-11-16       Impact factor: 3.906

9.  Ribonucleotide reductase large subunit M1 predicts poor survival due to modulation of proliferative and invasive ability of gastric cancer.

Authors:  Qinchuan Wang; Xiyong Liu; Jichun Zhou; Yasheng Huang; Shengjie Zhang; Jianguo Shen; Sofia Loera; Xiaoming Yuan; Wenjun Chen; Mei Jin; Stephen Shibata; Yingbin Liu; Peiguo Chu; Linbo Wang; Yun Yen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Germ cell specific overactivation of WNT/βcatenin signalling has no effect on folliculogenesis but causes fertility defects due to abnormal foetal development.

Authors:  Manish Kumar; Nicole J Camlin; Janet E Holt; Jose M Teixeira; Eileen A McLaughlin; Pradeep S Tanwar
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.